Direct-acting antiviral agents for patients with hepatitis C virus genotype 1 infection are cost-saving | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Direct-acting antiviral agents for patients with hepatitis C virus genotype 1 infection are cost-saving

Chhatwal J, He T, Hur C, Lopez-Olivo MA. Direct-acting antiviral agents for patients with hepatitis C virus genotype 1 infection are cost-saving. Clin Gastroenterol Hepatol. 2017;15(6):827-837.

Publication Type:

Journal Article

Authors:

Chhatwal, J.; He, T.; Hur, C; Lopez-Olivo, MA

Source:

Clin Gastroenterol Hepatol, Volume 15, Issue 6, p.827-837 (2017)

Cited On:

Overview of Cost, Reimbursement, and Cost-Effectiveness Considerations for Hepatitis C Treatment Regimens

Export Citation:

RIS Format

Top